BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36824294)

  • 1. Rescue Everolimus Post Lung Transplantation is Not Associated With an Increased Incidence of CLAD or CLAD-Related Mortality.
    Ivulich S; Paraskeva M; Paul E; Kirkpatrick C; Dooley M; Snell G
    Transpl Int; 2023; 36():10581. PubMed ID: 36824294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination.
    Ivulich S; Paul E; Kirkpatrick C; Dooley M; Snell G
    Transpl Int; 2023; 36():10704. PubMed ID: 36744051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
    Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes.
    Patrucco F; Allara E; Boffini M; Rinaldi M; Costa C; Albera C; Solidoro P
    Ther Adv Chronic Dis; 2021; 12():2040622321993441. PubMed ID: 33717427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
    Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
    Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors.
    Iasella CJ; Winstead RJ; Moore CA; Johnson BA; Feinberg AT; Morrell MR; Hayanga JWA; Lendermon EA; Zeevi A; McDyer JF; Ensor CR
    Transplantation; 2018 Jan; 102(1):171-177. PubMed ID: 28691954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
    Matsubara K; Otani S; Yamamoto H; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
    Surg Today; 2024 Apr; 54(4):317-324. PubMed ID: 37523071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation.
    Kubo Y; Sugimoto S; Shiotani T; Matsubara K; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Toyooka S
    Clin Transplant; 2023 Nov; 37(11):e15077. PubMed ID: 37461238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.
    Weigt SS; Kim GJ; Jones HD; Ramsey AL; Amubieya O; Abtin F; Pourzand L; Lee J; Shino MY; DerHovanessian A; Stripp B; Noble PW; Sayah DM; Saggar R; Britton I; Lynch JP; Belperio JA; Goldin J
    Transplantation; 2022 Jun; 106(6):1253-1261. PubMed ID: 34534193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
    Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
    Transpl Int; 2021; 35():10184. PubMed ID: 35185369
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
    Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
    J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus immunosuppression for renal protection, reduction of allograft vasculopathy and prevention of allograft rejection in de-novo heart transplant recipients: could we have it all?
    Gude E; Gullestad L; Andreassen AK
    Curr Opin Organ Transplant; 2017 Jun; 22(3):198-206. PubMed ID: 28463861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction.
    Wong W; Johnson B; Cheng PC; Josephson MB; Maeda K; Berg RA; Kawut SM; Harhay MO; Goldfarb SB; Yehya N; Himebauch AS
    J Heart Lung Transplant; 2023 May; 42(5):669-678. PubMed ID: 36639317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Lung Allograft Dysfunction.
    Venado A; Kukreja J; Greenland JR
    Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.